A detailed history of Virtus ETF Advisers LLC transactions in Savara Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 22,297 shares of SVRA stock, worth $94,539. This represents 0.05% of its overall portfolio holdings.

Number of Shares
22,297
Holding current value
$94,539
% of portfolio
0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.66 - $5.34 $81,607 - $119,065
22,297 New
22,297 $89,000
Q1 2019

May 14, 2019

SELL
$6.71 - $8.6 $270,466 - $346,648
-40,308 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$6.27 - $10.92 $252,731 - $440,163
40,308 New
40,308 $305,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $484M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.